UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000017381
Receipt No. R000020172
Scientific Title A Quasi-randomized, open-label, cross-over trial for development of a self-care program for the patient with secondary lymphedema
Date of disclosure of the study information 2015/05/01
Last modified on 2021/08/21 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title A Quasi-randomized, open-label, cross-over trial for development of a self-care program for the patient with secondary lymphedema
Acronym Development of a self-care program for the patients with secondary lymphedema
Scientific Title A Quasi-randomized, open-label, cross-over trial for development of a self-care program for the patient with secondary lymphedema
Scientific Title:Acronym Development of a self-care program for the patients with secondary lymphedema
Region
Japan

Condition
Condition Secondary lymphedema
Classification by specialty
Breast surgery Rehabilitation medicine Nursing
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To develop a self-care Complex Decongestive therapy (CDT) program for patient with secondary lymphedema
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes A value of segmental body composition measurement after intervention
Key secondary outcomes Limb circumference length
Limb volume
Edema volume
Viscoelasticity on skin surface
Lymphedema related symptoms
Lymphedema self-care
Physical activity

Base
Study type Interventional

Study design
Basic design Cross-over
Randomization Randomized
Randomization unit
Blinding Open -no one is blinded
Control Dose comparison
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Behavior,custom
Interventions/Control_1 Lymphedema self-care including bandaging during night-time
Interventions/Control_2 Lymphedema self-care including bandaging during day-time
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Female
Key inclusion criteria 1)unilateral secondary lymphedema
2)>=6 month from radiation treatment and/or chemotherapy
3)got the medical doctor's approval to take CDT and some medical devices in this study (e.g. MRI)
5)already applied with compression garment
Key exclusion criteria 1)taking a diuretic
2)Cancer recurrence
3)< 6 month from hospital CDT
Target sample size 30

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Etsuko Fujimoto
Organization Graduate school of medicine, Nagoya university
Division name Fundamental nursing
Zip code
Address 1-1-20, daiko-minami, higasi-ku, Nagoya, JAPAN
TEL 052-719-1568
Email fujimoto@met.nagoya-u.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Keisuke Nakanishi
Organization Graduate school of medicine, Nagoya university
Division name Doctoral course
Zip code
Address 1-1-20 Daiko-Minami, Higashi-ku, Nagoya City, JAPAN
TEL 090-9193-9679
Homepage URL
Email Knakanishi.keisuke@j.mbox.nagoya-u.ac.jp

Sponsor
Institute Graduate school of medicine
Institute
Department

Funding Source
Organization Nagoya University
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 05 Month 01 Day

Related information
URL releasing protocol
Publication of results Partially published

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2015 Year 05 Month 10 Day
Date of IRB
Anticipated trial start date
2015 Year 05 Month 27 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2015 Year 05 Month 01 Day
Last modified on
2021 Year 08 Month 21 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020172